Experts call for better cancer tests to tailor treatment

blood tubes

The need for more and better biomarker tests

Challenges to address

  • Companies and academic institutions need to continue to be incentivized to develop biomarker tests alongside new drugs—especially given that use of biomarkers can reduce the size of the patient population for a drug.
  • The Government needs to invest in better national infrastructure to support research into new biomarkers by making it easier to collect and access patient data and clinical samples.
  • We need a national directory for non-genomic biomarker tests, to supplement the National Genomic Test Directory—and the process for adding new tests needs to be accelerated.

‘The key to personalized medicine’

Getting treatments to the right patients

‘Knowing what biomarker a person may have could make all the difference’

Source: Read Full Article